Hörmann Mareike, Pavlidis Daphne, Brunkwall Jan, Gawenda Michael
Department of Vascular Surgery, University of Cologne, Cologne, Germany.
Interact Cardiovasc Thorac Surg. 2011 Oct;13(4):401-4. doi: 10.1510/icvts.2011.271312. Epub 2011 Jul 26.
Late aneurysm formation has been reported after every type of surgical coarctation repair in up to 10%, with rupture of such aneurysms being responsible for approximately 7% of all deaths. Secondary surgical repair carries a significant mortality (up to 15%) and morbidity rate (recurrent laryngeal nerve paralysis ∼20%, phrenic nerve injury ∼5%). According to the positive experience with endovascular therapy of atherosclerotic thoracic aortic aneurysms, it is worthwhile to evaluate the concept of minimally invasive endovascular stent grafting for secondary repair of postsurgical aneurysms.
Data were collected prospectively on consecutive patients who presented with postcoarctation false aneurysms.
Since 1999, in a cohort of 210 endovascularly treated patients with thoracic and thoracoabdominal aortic pathologies, four patients with postcoarctation false aneurysms underwent endoluminal stent-graft placement. All of these procedures were technically successful without 30-day or one-year procedure-related mortality. After a follow-up of 71 months in median (range, 7-93 months; mean, 60.5 months), all aneurysms remain excluded without any endoleak.
According to the current limited experience of small series, the endoluminal repair seems to be a promising alternative to redo open operations for postsurgical thoracic aneurysms associated with coarctation repair. Long-term follow-up of our small cohort confirmed the durability of the stent-graft treatment.
据报道,各类手术矫治主动脉缩窄后迟发性动脉瘤形成的发生率高达10%,此类动脉瘤破裂导致的死亡约占总死亡人数的7%。二次手术修复的死亡率(高达15%)和发病率(喉返神经麻痹约20%,膈神经损伤约5%)均较高。鉴于血管内治疗胸主动脉粥样硬化性动脉瘤取得了积极经验,评估采用微创血管内支架植入术对手术后继发动脉瘤进行二次修复的理念是值得的。
前瞻性收集连续出现主动脉缩窄后假性动脉瘤患者的数据。
自1999年以来,在一组210例接受血管内治疗的胸主动脉和胸腹主动脉病变患者中,4例主动脉缩窄后假性动脉瘤患者接受了腔内支架植入术。所有这些手术在技术上均获成功,无30天或1年手术相关死亡。中位随访71个月(范围7 - 93个月;平均60.5个月)后,所有动脉瘤均保持隔绝,无任何内漏。
根据目前小样本的有限经验,腔内修复对于与主动脉缩窄修复相关的手术后继发性胸主动脉瘤而言,似乎是再次开放手术的一种有前景的替代方法。我们小队列的长期随访证实了支架植入治疗的持久性。